Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®
Status:
Completed
Trial end date:
2018-01-04
Target enrollment:
Participant gender:
Summary
Phase III, multicenter, randomized, double-blinded, prospective study with two parallel
treatment groups. Patients who present to the hematologist/oncologist and satisfy all
inclusion and exclusion criteria will be eligible for participation in this 18-week study.